Small rewards lead to big wins for saving veterans’ lives
Peer-Reviewed Publication
Updates every hour. Last Updated: 31-Dec-2025 04:11 ET (31-Dec-2025 09:11 GMT/UTC)
Contingency management, which offers people small rewards for progress in recovering from drug addiction, was linked to fewer deaths in veterans with methamphetamine, cocaine or prescription drug issues.
Home care for older adults has received considerable attention in the Finnish media in recent years. Conducted at the University of Eastern Finland, a recent study found that newspaper images of home care tend to paint a picture of efficient care workers in a hectic work environment, while portraying older clients as passive recipients of care.
A major UK study, led by researchers at the University of Oxford’s Nuffield Department of Primary Care Health Sciences, Oxford University Hospitals NHS Foundation Trust, the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre, and Oxford Cancer, has provided the most comprehensive analysis to date of a cancer diagnosis pathway for patients presenting with non-specific symptoms (NSS), such as unexplained weight loss or fatigue. These symptoms can indicate a wide range of conditions, from benign diseases to late-stage cancers, making timely and accurate diagnosis a significant challenge in primary care.
Experiencing higher levels of gratitude could lead to lower financial stress, new research published in De Gruyter Brill’s Open Psychology suggests.
Researchers in China have combined network-pharmacology screening with molecular-docking validation to uncover, for the first time, a shared pharmacological network that connects sensitive-skin (SS) susceptibility with post-inflammatory hyperpigmentation (PIH). The findings provide a systematic target map for next-generation cosmeceuticals aimed at dual control of skin discomfort and uneven pigmentation. Researchers in China have combined network-pharmacology screening with molecular-docking validation to uncover, for the first time, a shared pharmacological network that connects sensitive-skin (SS) susceptibility with post-inflammatory hyperpigmentation (PIH). The findings provide a systematic target map for next-generation cosmeceuticals aimed at dual control of skin discomfort and uneven pigmentation.